![](/img/cover-not-exists.png)
Nonclinical pharmacokinetic evaluation of Eteplirsen, SRP-4045, and SRP-4053: Three Phosphorodiamidate morpholino oligomers (PMOs) for the treatment of patients with Duchenne muscular dystrophy (DMD)
Sazani, P., Charleston, J., Shanks, C., Zhang, J., Carver, M., Saoud, J., Kaye, E.Volume:
25
Language:
english
Journal:
Neuromuscular Disorders
DOI:
10.1016/j.nmd.2015.06.281
Date:
October, 2015
File:
PDF, 205 KB
english, 2015